Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Can GLP-1 Weight Loss Drugs Cause Scurvy? What to Know

    25. Februar 2026

    AdvaMed names Jake Leach as chair of diabetes sector

    24. Februar 2026

    A Million New STIs Are Contracted Every Day, the WHO Says

    24. Februar 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Midi Health Hits $1B Valuation with $100M
    News

    Midi Health Hits $1B Valuation with $100M

    HealthradarBy Healthradar4. Februar 2026Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Midi Health Hits B Valuation with 0M
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Midi Health Hits B Valuation with 0M

    What You Should Know

    • The Milestone: Midi Health has raised a $100M Series D, propelling its valuation over $1 billion. This “unicorn” status marks a pivotal moment for the women’s health sector, which has historically been underfunded.
    • The Pivot: While founded on menopause care, Midi is using this capital to expand into “lifelong care,” addressing gaps in cardiology, obesity, and longevity for women.
    • The Scale: The platform now serves 25,000 patients per week and covers 45 million women via insurance. To manage this volume, Midi is deploying an AI engine to automate chart analysis and clinical decision support.

    From Point Solution to Platform

    The most significant aspect of this announcement is not just the valuation, but the scope. Midi is transitioning from a “menopause company” to a “lifelong care platform.”

    The economic drivers for this are clear. Two million U.S. women enter menopause annually, and untreated symptoms cost the economy an estimated $25B a year. However, the health issues don’t stop at hot flashes. Midi is expanding its clinical remit to include cardiology, obesity, autoimmune survivorship, and longevity.

    By capturing the patient during perimenopause and retaining them through complex chronic care management, Midi is building a “longitudinal” relationship—the holy grail of digital health retention.

    AI at the Speed of 25,000 Visits a Week

    Scaling a specialist medical practice to a national level usually breaks the operational model. Midi is currently seeing more than 25,000 patients per week. To handle this volume without burning out clinicians, the company is leaning heavily on AI.

    Midi’s proprietary AI engine is being used to:

    1. Personalize Care: AI-powered chart analysis tailors the patient journey before the doctor even joins the video call.
    2. Streamline Operations: Automating triage and documentation to reduce the “pajama time” (after-hours charting) for providers.
    3. Refine Protocols: Mining one of the industry’s largest datasets on midlife women to fuel research and improve outcomes.

    Appoints Jason Wheeler as CFO

    To manage this hyper-growth, Midi is importing executive talent from the tech elite. The company announced the hiring of Jason Wheeler as CFO—a veteran with leadership roles at Tesla and Google. Alongside new CMO Melissa Waters (ex-Meta/Lyft) and CCO Matt Cook, the executive bench is being fortified for a potential IPO path.

    “This is validation for the movement we’re leading,” said Joanna Strober, co-founder and CEO of Midi Health. “Women’s health has been treated like an afterthought for too long.”



    Source link

    100M femtech Health hits Midi valuation
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleUltra-processed foods have more in common with cigarettes than vegetables, study finds
    Next Article Fewer Screenings Needed for Those Who Get HPV Shot
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    AdvaMed names Jake Leach as chair of diabetes sector

    24. Februar 2026
    News

    AdvaMed urges tailored tariff approach for medtech

    24. Februar 2026
    News

    ‘A deal is a deal’: EU halts US pact over Trump’s new global tariff

    23. Februar 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202588 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202563 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202536 Views

    Dexcom raises sales expectations, discusses G8 plans

    31. Juli 202526 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202588 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202563 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.